Thus, a significant increase of NADK, a decrease of NNMT1, and a decrease of ENPP1 can be considered relevant specific biomarkers for HNSCC, LuSCC, or CeSCC, respectively. This evidence concerns the gene ENPP1 and head and neck squamous cell carcinoma.